Jupiter Wellness Retires Approximately 10% Of Its Outstanding Shares

Jupiter Wellness, Inc. JUPW purchased and retired 2,43 million common shares, which reduces the company's outstanding common shares to 22.15 million an approximate 10% reduction in shares outstanding.

The company has a $5.0 million share buyback program. Under the program, shares of the company's stock may be repurchased periodically in the open market or privately negotiated transactions. To date, the company has purchased 2.43 million under the program.

"We continue to believe our stock is undervalued and today's announcement shows continued commitment to our shareholders and the desire to retire shares at current market prices. Given our current cash position, I strongly feel this program is an attractive use of capital as we continue to reposition ourselves for the growth ahead," stated Brian John, CEO of Jupiter Wellness.

About Jupiter Wellness

Jupiter Wellness translates health science into products aimed at skin, hair, sexual wellness, and general health. The company’s approach is defined by proven mechanisms of action, validated manufacturing processes, and controlled clinical trials. Jupiter Wellness development pipeline includes products to address psoriasis, eczema, burns, herpes, cold sores, and skin cancer. The company generates revenue from a growing line of over-the-counter skin care products, wellness brands sold through retail channels, and the licensing of its intellectual property and proprietary formulations.

Related News

Jupiter Wellness To Offer Clinical Research Services With Acquisition Of Ascent Clinical Research

Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders

Jupiter Wellness & Next Frontier Pharmaceuticals Merge, Will Expand Cannabinoid & Psychedelics Drug Development

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksMarketsBrian John
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.